Table 2.
Descriptive Statistics for Outcome Variables at Each Time Point in the Postmenopausal and Premenopausal Samples
| T1: Pre-Tx Mean (SD) |
T2: Post-Tx Mean (SD) |
T3: Follow-Up Mean (SD) |
|
|---|---|---|---|
|
Study 1: Postmenopausal Women
| |||
| BDI-II (Depression) | |||
| CT | 4.11 (4.07) | 4.07 (4.23) | 3.24 (3.82) |
| No-CT | 5.13 (6.26) | 4.45 (6.03) | 5.81 (7.14) |
| Total | 4.57 (5.34) | 4.27 (5.19) | 4.55 (5.85) |
| MFSI-SF (Fatigue) | |||
| CT | 8.50 (18.98) | 9.52 (16.94) | 4.04 (14.77) |
| No-CT | 7.10 (14.81) | 5.55 (17.59) | 7.50 (21.13) |
| Total | 7.86 (17.10) | 7.47 (17.25) | 5.80 (18.20) |
| PSQI (Sleep Quality) | |||
| CT | 6.94 (3.32) | 6.55 (3.00) | 6.36 (4.05) |
| No-CT | 8.00 (3.96) | 6.94 (3.91) | 8.08 (4.58) |
| Total | 7.42 (3.63) | 6.75 (3.47) | 7.24 (4.37) |
|
| |||
|
Study 2: Premenopausal Women
| |||
| HADS-D (Depression) | 3.25 (3.04) | 3.95 (3.13) | 3.55 (3.60) |
| MFSI-SF (Fatigue) | 9.11 (18.30) | 17.88 (20.33) | 11.82 (23.54) |
| PSQI (Sleep Quality) | 7.35 (4.19) | 8.94 (4.35) | 7.28 (4.10) |
CT = chemotherapy group; No-CT = no chemotherapy group; BDI-II = Beck Depression Inventory-Second Edition (Cognitive-Affective subscale); PSQI = Pittsburgh Sleep Quality Index; MFSI-SF = Multidimensional Fatigue Symptom Inventory-Short Form; HADS-D = Hospital Anxiety and Depression Scale-Depression subscale.